Emerging Pharmaceutical Markets Globally

1. Analyst View

2. Global Pharmaceutical Market

• 2.1 Market Size
• 2.2 Mature Markets - G7 Countries
• 2.3 Emerging Markets - E7 Countries
• 2.4 E7 Countries to Grow Strongly

3. Why E7 Pharmaceutical Market?

• 3.1 Economic Growth
• 3.2 Income Level
• 3.3 Population Base
• 3.4 Prevalence of Lifestyle-related Diseases
• 3.5 Medical & Distribution Infrastructure
• 3.6 Health Insurance

4. Industry Performance

• 4.1 Brazil (Past, Present & Future Scenario)
  • 4.1.1 Macroeconomic Indicators
  • 4.1.2 Population Profile
  • 4.1.3 Disease Profile
  • 4.1.4 Healthcare Spending & Financing
  • 4.1.5 Pharmaceutical Market
  • 4.1.6 Import & Export
  • 4.1.7 Generic Drugs
  • 4.1.8 Therapy Areas
  • 4.1.9 Key Players
• 4.2 Russia (Past, Present & Future Scenario)
  • 4.2.1 Macroeconomic Indicators
  • 4.2.2 Population Profile
  • 4.2.3 Disease Profile
  • 4.2.4 Healthcare Spending & Financing
  • 4.2.5 Pharmaceutical Market
  • 4.2.6 Import
  • 4.2.7 Branded & Generic Drugs
  • 4.2.8 Therapy Areas
  • 4.2.9 Key Players
• 4.3 India (Past, Present & Future Scenario)
  • 4.3.1 Macroeconomic Indicators
  • 4.3.2 Population Profile
  • 4.3.3 Disease Profile
  • 4.3.4 Healthcare Spending & Financing
  • 4.3.5 Pharmaceutical Market
  • 4.3.6 Import & Export
  • 4.3.7 Branded & Generic Drugs
  • 4.3.8 Therapy Areas
  • 4.3.9 Key Players
• 4.4 China (Past, Present & Future Scenario)
  • 4.4.1 Macroeconomic Indicators
  • 4.4.2 Population Profile
  • 4.4.3 Disease Profile
  • 4.4.4 Healthcare Spending & Financing
  • 4.4.5 Pharmaceutical Market
  • 4.4.6 Import & Export
  • 4.4.7 Branded & Generic Drugs
  • 4.4.8 Therapy Areas
  • 4.4.9 Key Players
• 4.5 Turkey (Past, Present & Future Scenario)
  • 4.5.1 Macroeconomic Indicators
  • 4.5.2 Population Profile
  • 4.5.3 Disease Profile
  • 4.5.4 Healthcare Spending & Financing
  • 4.5.5 Pharmaceutical Market
  • 4.5.6 Import & Export
  • 4.5.7 Branded & Generic Drugs
  • 4.5.8 Therapy Areas
  • 4.5.9 Key Players
• 4.6 Mexico (Past, Present & Future Scenario)
  • 4.6.1 Macroeconomic Indicators
  • 4.6.2 Population Profile
  • 4.6.3 Disease Profile
  • 4.6.4 Healthcare Spending & Financing
  • 4.6.5 Pharmaceutical Market
  • 4.6.6 Import & Export
  • 4.6.7 Branded & Generic Drugs
  • 4.6.8 Therapy Areas
  • 4.6.9 Key Players
• 4.7 Indonesia (Past, Present & Future Scenario)
  • 4.7.1 Macroeconomic Indicators
  • 4.7.2 Population Profile
  • 4.7.3 Disease Profile
  • 4.7.4 Healthcare Spending & Financing
  • 4.7.5 Pharmaceutical Market
  • 4.7.6 Import & Export
  • 4.7.7 Branded & Generic Drugs
  • 4.7.8 Key Players

5. Opportunities

• 5.1 Chronic Diseases
• 5.2 Pharma Outsourcing Market
• 5.3 Vaccine Market
• 5.4 Medical Devices Market

6. Restraining Forces

• 6.1 Counterfeit Drugs
• 6.2 Patent Protection
• 6.3 Traditional Medicines

7. Key Players

• 7.1 GlaxoSmithKline
• 7.2 Sanofi-Aventis
• 7.3 Pfizer Inc.
• 7.4 Novartis
• 7.5 AstraZeneca

• Figure 2-1: Global - Pharmaceutical Market* (in Billion US$), 2001-2007E
• Figure 2-2: Global - Forecast for Pharmaceutical Market* (in Billion US$), 2008-2012
• Figure 2-3: G7 Countries - Pharmaceutical Markets (in Billion US$), 2007E
• Figure 2-4: G7 Countries - Forecast for Pharmaceutical Markets (in Billion US$), 2012
• Figure 2-5: G7 Countries - CAGR Growth of Pharmaceutical Markets (%), 2007-2012
• Figure 2-6: E7 Countries - Pharmaceutical Markets (in Billion US$), 2007E
• Figure 2-7: E7 Countries - Forecast for Pharmaceutical Markets (in Billion US$), 2012
• Figure 2-8: E7 Countries - CAGR Growth of Pharmaceutical Markets (%), 2007-2012
• Figure 2-9: Global - Pharmaceutical Market by E7 & G7 Countries (%), 2007E & 2012F
• Figure 2-10: Global - Share of E7 & G7 Countries in Pharmaceutical Market Growth (%), 2007-2012
• Figure 3-1: G7 Countries - Real GDP (in Trillion US$), 2004 & 2012F
• Figure 3-2: E7 Countries - Real GDP (in Trillion US$), 2004 & 2012F
• Figure 3-3: Global - Share of E7 & G7 Countries in Population (%), 2007E & 2012F
• Figure 3-4: Relative Per Capita Spending on Drugs by Age Group
• Figure 3-5: India - Prevalence of various Lifestyle-related Diseases (in Million), 2005 & 2015F
• Figure 4-1: Brazil - Nominal GDP (in Billion US$), 2005-2012F
• Figure 4-2: Brazil - Consumer Price Index (%), 2005-2012F
• Figure 4-3: Brazil - Currency Exchange Rate (From US$ to BRL), 2005-2012F
• Figure 4-4: Brazil - Foreign Direct Investment (in Billion US$), 2004-2007
• Figure 4-5: Brazil - Population (in Million), 2005-2012F
• Figure 4-6: Brazil - Breakup of Population by Age Group (%), 2005-2012F
• Figure 4-7: Brazil - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
• Figure 4-8: Brazil - Number of Deaths due to Leading Causes (in ' 000), 2005
• Figure 4-9: Brazil - Breakup of Deaths by various Causes (%), 2005-2012F
• Figure 4-10: Brazil - Per Head Healthcare Spending (in US$), 2004-2012F
• Figure 4-11: Brazil - Breakup of Healthcare Payment by Source (%), 2006
• Figure 4-12: Brazil - Pharmaceutical Market (in Billion BRL), 2001, 2002 & 2004-2007E
• Figure 4-13: Brazil - Pharmaceutical Market (in Billion Units), 2004-2007E
• Figure 4-14: Brazil - Forecast for Pharmaceutical Market (in Billion BRL), 2008-2012
• Figure 4-15: Brazil - Pharmaceutical Imports (in Billion US$), 2004-2007E
• Figure 4-16: Brazil - Pharmaceutical Exports (in Million US$), 2004-2007E
• Figure 4-17: Brazil - Generic Drugs (in Million US$), 2004-2007E
• Figure 4-18: Brazil - Forecast for Generic Drugs (in Million US$), 2008-2012
• Figure 4-19: Brazil - Share of Generic Drugs in Pharmaceutical Market* (%), 2007E & 2012F
• Figure 4-20: Brazil - Breakup of Pharmaceutical Market by Segment (%), Dec 2007
• Figure 4-21: Russia - Nominal GDP (in Billion US$), 2005-2012F
• Figure 4-22: Russia - Consumer Price Index (%), 2005-2012F
• Figure 4-23: Russia - Currency Exchange Rate (From US$ to RUB), 2005-2012F
• Figure 4-24: Russia - Foreign Direct Investment (in Billion US$), 2004-2007
• Figure 4-25: Russia - Population (in Million), 2005-2012F
• Figure 4-26: Russia - Breakup of Population by Age Group (%), 2005-2012F
• Figure 4-27: Russia - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
• Figure 4-28: Russia - Number of Deaths due to Leading Causes (in ' 000), 2005
• Figure 4-29: Russia - Breakup of Deaths by various Causes (%), 2005-2012F
• Figure 4-30: Russia - Per Head Healthcare Spending (in US$), 2004-2012F
• Figure 4-31: Russia - Breakup of Healthcare Payment by Source (%), 2005
• Figure 4-32: Russia - Domestic Pharmaceutical Market (in Billion US$), 2005-2007E
• Figure 4-33: Russia - Domestic Pharmaceutical Market by Segment (in Billion US$), 2005-2007E
• Figure 4-34: Russia - Forecast for Domestic Pharmaceutical Market (in Billion US$), 2008-2012
• Figure 4-35: Russia - Pharmaceutical Imports (in Billion US$), 2005-2007E
• Figure 4-36: Russia - Breakup of Pharmaceutical Market* by Branded & Generic Drugs (%), 2005
• Figure 4-37: India - Nominal GDP (in Billion US$), 2005-2012F
• Figure 4-38: India - Consumer Price Index (%), 2005-2012F
• Figure 4-39: India - Currency Exchange Rate (From US$ to INR), 2005-2012F
• Figure 4-40: India - Foreign Direct Investment (in Billion US$), 2002-03 to 2006-07
• Figure 4-41: India - Foreign Direct Investment in Pharmaceutical Market (in Million US$), 2003-04 to 2006-07
• Figure 4-42: India - Population (in Million), 2005-2012F
• Figure 4-43: India - Breakup of Population by Age Group (%), 2005-2012F
• Figure 4-44: India - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
• Figure 4-45: India - Number of Deaths due to Leading Causes (in ' 000), 2005
• Figure 4-46: India - Breakup of Deaths by various Causes (%), 2005-2012F
• Figure 4-47: India - Per Head Healthcare Spending (in US$), 2005-2012F
• Figure 4-48: India - Breakup of Healthcare Payment by Source (%), 2006
• Figure 4-49: India - Domestic Pharmaceutical Market* (in Billion INR), 2001-02 to 2006-07
• Figure 4-50: India - Forecast for Domestic Pharmaceutical Market* (in Billion INR), 2007-08 to 2011-12
• Figure 4-51: India - Pharmaceutical Imports (in Billion INR), 2000-01 to 2006-07E
• Figure 4-52: India - Pharmaceutical Exports (in Billion INR), 2005-06 to 2011-12F
• Figure 4-53: India - Breakup of Domestic Pharmaceutical Market by Segment (%), 2004 & 2010F
• Figure 4-54: India - Share of Top Players in Pharmaceutical Market (%), 2006
• Figure 4-55: China - Nominal GDP (in Billion US$), 2005-2012F
• Figure 4-56: China - Consumer Price Index (%), 2005-2012F
• Figure 4-57: China - Currency Exchange Rate (From US$ to CNY), 2005-2012F
• Figure 4-58: China - Foreign Direct Investment (in Billion US$), 2004-2007
• Figure 4-59: China - Population (in Million), 2005-2012F
• Figure 4-60: China - Breakup of Population by Age Group (%), 2005-2012F
• Figure 4-61: China - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
• Figure 4-62: China - Number of Deaths due to Leading Causes (in ' 000), 2005
• Figure 4-63: China - Breakup of Deaths by various Causes (%), 2005-2012F
• Figure 4-64: China - Per Head Healthcare Spending (in US$), 2004-2012F
• Figure 4-65: China - Breakup of Healthcare Payment by Source (%), 2006
• Figure 4-66: China - Domestic Pharmaceutical Market (in Billion US$), 1996, 2000 & 2005-2007E
• Figure 4-67: China - TCM Market (in Billion CNY), 2005-2007E
• Figure 4-68: China - Pharmaceutical Purchase by Source (%), 2003
• Figure 4-69: China - Forecast for Domestic Pharmaceutical Market (in Billion US$), 2008-2012
• Figure 4-70: China - Medicine & Health Product Imports (in Billion US$), 2005-2007E
• Figure 4-71: China - Breakup of Medicine & Health Product Imports by Type (%), 2006
• Figure 4-72: China - Medicine & Health Product Exports (in Billion US$), 2005-2007E
• Figure 4-73: China - Breakup of Medicine & Health Product Exports by Type (%), 2006
• Figure 4-74: China - Breakup of Domestic Pharmaceutical Market by Segment (%), 2003
• Figure 4-75: Turkey - Nominal GDP (in Billion US$), 2005-2012F
• Figure 4-76: Turkey - Consumer Price Index (%), 2005-2012F
• Figure 4-77: Turkey - Currency Exchange Rate (From US$ to TRY), 2005-2012F
• Figure 4-78: Turkey - Foreign Direct Investment (in Billion US$), 2004-2007
• Figure 4-79: Turkey - Population (in Million), 2005*-2012F
• Figure 4-80: Turkey - Breakup of Population by Age Group (%), 2005*-2012F
• Figure 4-81: Turkey - Population in the Age Group of 65 Years & Above (in Million), 2005*-2012F
• Figure 4-82: Turkey - Number of Deaths due to Leading Causes (in ' 000), 2005
• Figure 4-83: Turkey - Breakup of Deaths by various Causes (%), 2005-2012F
• Figure 4-84: Turkey - Per Head Healthcare Spending (in US$), 2004-2012F
• Figure 4-85: Turkey - Breakup of Healthcare Payment by Source (%), 2005
• Figure 4-86: Turkey - Domestic Pharmaceutical Market (in Billion US$), 2005-2007E
• Figure 4-87: Turkey - Domestic Pharmaceutical Market (in Million Boxes), 2002-2007E
• Figure 4-88: Turkey - Forecast for Domestic Pharmaceutical Market (in Billion US$), 2008-2012
• Figure 4-89: Turkey - Breakup of Pharmaceutical Market* by Imported & Locally-produced Drugs (%), 2004-2007E
• Figure 4-90: Turkey - Pharmaceutical Exports (in Million US$), 2004-2007E
• Figure 4-91: Turkey - Breakup of Pharmaceutical Market Sales Value* by Branded & Generic Drugs (%), 2004- 2007E
• Figure 4-92: Turkey - Breakup of Pharmaceutical Market Sales Volume* by Branded & Generic Drugs (%), 2004-2007E
• Figure 4-93: Mexico - Nominal GDP (in Billion US$), 2005-2012F
• Figure 4-94: Mexico - Consumer Price Index (%), 2005-2012F
• Figure 4-95: Mexico - Currency Exchange Rates (From US$ to MXN), 2005-2012F
• Figure 4-96: Mexico - Foreign Direct Investment (in Billion US$), 2004-2007
• Figure 4-97: Mexico - Population (in Million), 2005-2012F
• Figure 4-98: Mexico - Breakup of Population by Age Group (%), 2005-2012F
• Figure 4-99: Mexico - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
• Figure 4-100: Mexico - Number of Deaths due to Leading Causes (in ' 000), 2005
• Figure 4-101: Mexico - Breakup of Deaths by various Causes (%), 2005-2012F
• Figure 4-102: Mexico - Per Head Healthcare Spending (in US$), 2004-2012F
• Figure 4-103: Mexico - Breakup of Healthcare Payment by Source (%), 2004
• Figure 4-104: Mexico - Domestic Pharmaceutical Market (in Billion Pesos), 2004-2007E
• Figure 4-105: Mexico - Forecast for Domestic Pharmaceutical Market (in Billion Pesos), 2008-2012
• Figure 4-106: Mexico - Pharmaceutical Imports (in Billion US$), 2003 & 2007E
• Figure 4-107: Mexico - Pharmaceutical Exports (in Billion US$), 2003, 2006 & 2007E
• Figure 4-108: Mexico - Breakup of Pharmaceutical Market* by Branded & Generic Drugs (&), 2004
• Figure 4-109: Mexico - Generic Market (in Billion MXN), 2003 & 2004
• Figure 4-110: Mexico - Share of Top Players in Pharmaceutical Market (%), 2007
• Figure 4-111: Indonesia - Nominal GDP (in Billion US$), 2005-2012F
• Figure 4-112: Indonesia - Consumer Price Index (%), 2005-2012F
• Figure 4-113: Indonesia - Currency Exchange Rates (From US$ to Rp), 2005-2012F
• Figure 4-114: Indonesia - Foreign Direct Investment (in Billion US$), 2005-2007
• Figure 4-115: Indonesia - Population (in Million), 2005-2012F
• Figure 4-116: Indonesia - Breakup of Population by Age Group (%), 2005-2012F
• Figure 4-117: Indonesia - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
• Figure 4-118: Indonesia - Number of Deaths due to Leading Causes (in ' 000), 2005
• Figure 4-119: Indonesia - Breakup of Deaths by various Causes (%), 2005-2012F
• Figure 4-120: Indonesia - Per Head Healthcare Spending (in US$), 2004-2012F
• Figure 4-121: Indonesia - Breakup of Healthcare Payment by Source (%), 2003
• Figure 4-122: Indonesia - Domestic Pharmaceutical Market (in Billion Rp), 2000-2007E
• Figure 4-123: Indonesia - Prescription & OTC Drugs Market (in Billion Rp), 2000-2007E
• Figure 4-124: Indonesia - Forecast for Domestic Pharmaceutical Market (in Billion Rp), 2008-2012
• Figure 4-125: Indonesia - Pharmaceutical Exports (in Billion Rp) 2001-2005
• Figure 4-126: Indonesia - Pharmaceutical Imports (in Billion Rp) 2001-2005
• Figure 4-127: Indonesia - Breakup of Pharmaceutical Market by Branded & Generic Drugs (%), 2005
• Figure 4-128: Indonesia - Share of Top Players in Prescription Pharmaceutical Market (%), 2005
• Figure 4-129: Indonesia - Share of Top Players in OTC Pharmaceutical Market (%), 2005
• Figure 5-1: Global - Pharma Outsourcing Market by Segment (%), 2006
• Figure 5-2: BRIC Countries - Medical Device Market (in Million US$), 2006

• Table 2-1: Global - Pharmaceutical Market* by Region (in Billion US$), 2006
• Table 3-1: E7 Countries - Disposable Income (in Million US$), 2007E & 2012F
• Table 3-2: G7 Countries - Population (in Million), 2007E & 2012F
• Table 3-3: E7 Countries - Population (in Million), 2007E & 2012F
• Table 3-4: G7 Countries - Population in the Age Group of 65 Years & Above (in Million), 2007E & 2012F
• Table 3-5: E7 Countries - Population in the Age Group of 65 Years & Above (in Million), 2007E & 2012F
• Table 4-1: Brazil - Statistics of Top 10 Players in Pharmaceutical Market, 2006
• Table 4-2: Russia - Statistics of ATC Groups in Commercial Drugs Market, 2006
• Table 4-3: Russia - Statistics of ATC Groups under DLO Programme, 2006
• Table 4-4: Russia - Performance of Key Players in Pharmaceutical Market* (in Million US$), 2005 & 2006
• Table 4-5: Russia - Performance of Key Players in Pharmaceutical Market (%), H1 2006 & H1 2007
• Table 4-6: India - Performance of Drugs by Therapeutic Segment in Domestic Pharmaceutical Market (%), 2006
• Table 4-7: India - Performance of Top 20 Pharmaceutical Players, 2006
• Table 4-8: China - Performance* of Drugs by Therapeutic Segment in Pharmaceutical Market (%), 2005 & 2006
• Table 4-9: China - Performance* of Key Players in Pharmaceutical Market (H1 2006 & H1 2007)
• Table 4-10: Turkey - Performance* of Therapy Areas in Pharmaceutical Market (%), 2005 & 2006
• Table 4-11: Turkey - Top 20 Pharmaceutical Players by Sales Value (Jan-Sep 2007)
• Table 4-12: Turkey - Top 20 Pharmaceutical Players by Sales Volume (Jan-Sep 2007)
• Table 4-13: Mexico - Performance of Therapy Areas in Retail Pharmaceutical Market, 2006
• Table 5-1: India - Market for Various Chronic Diseases (in Billion INR), 2006 & 2010F
• Table 5-2: India, China & Brazil - Vaccine Market (in Million US$), 2006E & 2010F
• Table 7-1: GlaxoSmithKline - Key Financials (in Million US$), 2004-2006
• Table 7-2: Sanofi-Aventis - Key Financials (in Million US$), 2004-2006
• Table 7-3: Pfizer Inc. - Key Financials (in Million US$), 2004-2006
• Table 7-4: Novartis - Key Financials (in Million US$), 2004-2006
• Table 7-5: AstraZeneca - Key Financials (in Million US$), 2004 & 2005